Insight Molecular Diagnostics Prices $15 Million Public Offering

PUBT · 1d ago
Insight Molecular Diagnostics Prices $15 Million Public Offering
  • Insight Molecular Diagnostics priced a roughly $15 million public offering, including 8,296,429 common shares at $1.75 each, before fees and expenses.
  • Pre-funded warrants cover 275,000 common shares at $1.7499 each, with an exercise price of $0.0001 per share.
  • The underwriter has a 30-day option to purchase 1,285,714 additional common shares at the public offering price, less underwriting discounts and commissions.
  • Closing is expected on or about November 18, 2026, subject to customary conditions.
  • Net proceeds will fund working capital and general corporate purposes, including transplantation research and development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611170800PRIMZONEFULLFEED9879210) on November 17, 2026, and is solely responsible for the information contained therein.